09:01 GLOBAL BIO-CHEM<00809> - Results Announcement Global Bio-Chem Technology Group Company Limited announced on 12/04/2005: (stock code: 00809 ) Year end date: 31/12/2004 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/01/2004 from 01/01/2003 to 31/12/2004 to 31/12/2003 Note ('000 ) ('000 ) Turnover : 3,375,593 2,329,819 Profit/(Loss) from Operations : 1,018,800 662,371 Finance cost : (28,029) (23,873) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : (1,479) (2,244) Profit/(Loss) after Tax & MI : 815,451 520,772 % Change over Last Period : +57 % EPS/(LPS)-Basic (in dollars) : 0.389 0.265 -Diluted (in dollars) : 0.384 0.255 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 815,451 520,772 Final Dividend : 5.0 Cents 2.5 Cents per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : 17/05/2005 to 18/05/2005 bdi. Payable Date : 07/06/2005 B/C Dates for Annual General Meeting : 17/05/2005 to 18/05/2005 bdi. Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1 PROFIT FROM OPERATING ACTIVITIES Profit from operating activities for the year is approximately HK$1,018, 800,000 (2003: HK$662,371,000). 2. EARNINGS PER SHARE The calculation of basic earnings per share is based on the consolidated net profit from ordinary activities attributable to shareholders for the year of approximately HK$815,451,000 (2003: HK$520,772,000), and the weighted average number of 2,098,801,983 (2003: 1,963,138,555) ordinary shares in issue during the year. The calculation of diluted earnings per share is based on the consolidated net profit from ordinary activities attributable to shareholders for the year of approximately HK$815,451,000 (2003: HK$520, 772,000) and on 2,124,158,672 (2003: 2,038,370,758) ordinary shares, being the weighted average number of 2,098,801,983 (2003: 1,963,138,555) ordinary shares in issue during the year, as used in the basic earnings per share calculation, plus the weighted average of 25,356,689 (2003: 75, 232,203) ordinary shares assumed to have been issued at no consideration on the deemed exercise of all share options during the year. In addition, as the exercise price of the warrants was higher than the average market price of the Company's ordinary shares during the year, no shares were assumed to have been issued on deemed exercise of the Company's warrants during the year. For more details, please refer to the press announcement today.